Health Digital Twins in Life Science and Health Care Innovation

Area of Science:

• Biomedical Informatics
• Computational Biology
• Digital Health

Background:

• Health digital twins (HDTs) are sophisticated virtual replicas of individuals.
• HDTs enable the simulation of human physiology, disease progression, and therapeutic interventions.
• Current applications are expanding beyond research into clinical decision-making and public health.

Purpose of the Study:

• To explore the transformative potential of HDTs in drug discovery and development.
• To highlight the role of HDTs in advancing precision therapies and clinical decision support.
• To discuss the implications of scaled HDT deployment for public health monitoring.

Main Methods:

• Utilizing virtual patient models for in silico experimentation.
• Leveraging data-driven approaches for target selection and clinical trial design.
• Simulating physiological responses and drug efficacy within a digital environment.

Main Results:

• HDTs offer a data-driven pathway to optimize drug discovery and development processes.
• The technology facilitates personalized treatment strategies and enhances clinical decision-making.
• Scaled HDT implementation promises a precise approach to public health surveillance and intervention.

Conclusions:

• HDTs represent a significant advancement in personalized medicine and pharmaceutical research.
• Addressing socioeconomic barriers and data representativeness are critical for equitable HDT deployment.
• Establishing robust governance and regulatory frameworks is essential for the responsible advancement of HDT technology.